# Cardinal Analytx funding: rounds and investors > Cardinal Analytx has raised $28M across 2 rounds since 2017. Investors include John Doerr, Stanford-StartX and Premera Blue Cross. Every round with its source. Source: https://millionrounds.com/company/cardinal-analytx (Millionrounds; every figure on the page links to its filing or article) United States · [Series B startup](https://millionrounds.com/companies) # Who invested in *Cardinal Analytx* 2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$28M** raised across 2 rounds since 2017, from 2 sources **$6.1M** Series A **$22M** Series B - **Latest round:** Series B, $22M May 2019 - **Led by:** John Doerr - **Step-up i:** 3.6× - **Investors:** 6 (1 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2018 2019 **$6.1M** Series A **$22M** Series B - **First round:** Series A, $6.1M - **Biggest round:** $22M - **Between rounds:** 20 months [**Cardinal Analytx** Biotech/health 1 / 12 Their pitch deck **Cardinal Analytx's pitch deck, 12 slides** Each slide read for what it argues, against the decks that raised at the same stage.](https://millionrounds.com/decks/cardinal-analytx) ## The rounds - **May 2019** Series B **$22M** *4 new* [John Doerr](https://millionrounds.com/fund/john-doerr) Lead [Premera Blue Cross](https://millionrounds.com/fund/premera-blue-cross) Blue Shield California GuideWell Mutual Holding Reported by FinSMEs SEC filing: $21M sold, first sale Mar 2019 - **Sept 2017** Series A **$6.1M** *2 new* [Stanford-StartX](https://millionrounds.com/fund/stanford-startx) Cardinal Partners/ Premera Blue Cross Reported by FinSMEs SEC filing: $2.8M sold, first sale May 2017 ## Founders and team From the SEC filings it signed: 2 on the team. - **Linda T. Hand** Executive Officer, Director i - **Niall T. O'Cathasaigh** Executive Officer i On the board, as filed i *Elizabeth T. Spaulding* *Kent T. Marquardt* *Mark T. Smith* *Thomas T. McKinley* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2017 **Series B** 2019 [John Doerr](https://millionrounds.com/fund/john-doerr) L [Stanford-StartX](https://millionrounds.com/fund/stanford-startx) [Premera Blue Cross](https://millionrounds.com/fund/premera-blue-cross) Blue Shield California Cardinal Partners/ Premera Blue Cross GuideWell Mutual Holding ## Everyone who backed them [John Doerr](https://millionrounds.com/fund/john-doerr) VC firm **1** round, led 1 [Stanford-StartX](https://millionrounds.com/fund/stanford-startx) Investment firm **1** round [Premera Blue Cross](https://millionrounds.com/fund/premera-blue-cross) Corporate VC **1** round Blue Shield California no record of our own yet **1** round Cardinal Partners/ Premera Blue Cross no record of our own yet **1** round GuideWell Mutual Holding no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=cardinal-analytx). ## Quick answers about Cardinal Analytx ### Who invested in Cardinal Analytx? Cardinal Analytx's investors include John Doerr, Stanford-StartX, Premera Blue Cross, Blue Shield California and Cardinal Partners/ Premera Blue Cross, and 1 more on record. John Doerr led its latest round. ### How much has Cardinal Analytx raised? Cardinal Analytx has raised $28M across 2 rounds since 2017. ### When did Cardinal Analytx last raise? Cardinal Analytx's most recent round was a Series B of $22M in May 2019, led by John Doerr. ### What was Cardinal Analytx's biggest round? Its most recent round, $22M in May 2019, is also its largest on record. ### Who backed Cardinal Analytx first? Cardinal Analytx's first round on record, in Sept 2017, was backed by Stanford-StartX and Cardinal Partners/ Premera Blue Cross. ### What stage is Cardinal Analytx at? Cardinal Analytx's latest named round is a Series B, in May 2019. ### Where is Cardinal Analytx based? Cardinal Analytx is based in the United States. ### Who led Cardinal Analytx's rounds? John Doerr led the Series B in 2019. ## Companies like Cardinal Analytx In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app